Catalog No.
Product Name
Application
Product Information
Citations
-
Ferroptosis Inducer
Anticancer agent 194 is a potent ferroptosis inducer that also promotes autophagy. This compound selectively arrests the colon cancer cell cycle at the G2/M phase while not triggering apoptotic pathways. Anticancer agent 194 exerts its biological effects through the significant accumulation of reactive oxygen species (ROS), making it a valuable tool for research on ferroptosis and cancer therapy strategies. -
Ferroptosis Inhibitor
Ferroptosis-IN-6 is a potent ferroptosis inhibitor with an EC50 of 25.5 nM. This compound effectively inhibits RSL3-induced cell death both in vitro and in vivo, making it a valuable tool for studying ferroptosis mechanisms. Its applications include investigating cell death pathways and potential therapeutic strategies in cancer and neurodegenerative diseases. -
Ferroptosis Inhibitor
CuATSP is a potent inhibitor of ferroptotic cell death, demonstrating approximately 20-fold greater efficacy compared to its predecessor, CuATSM. This compound has significant implications for research focused on cell death mechanisms and oxidative stress-related diseases. It is valuable for studying the pathways involved in ferroptosis and its potential therapeutic applications in various conditions, including neurodegenerative disorders and cancer. -
Ferroptosis Regulator
2-Acetamidophenol, an ortho-regioisomer of Paracetamol, serves as a ferroptosis regulator, primarily influencing glutathione metabolic pathways. This compound exhibits anti-atherosclerotic properties, effectively reducing total cholesterol and triglyceride levels in zebrafish hyperlipidemia models with IC50 values of 30 μM and 40 μM, respectively. Additionally, 2-Acetamidophenol promotes the expression of genes associated with glutathione synthesis and iron ion transport, mitigates intracellular reactive oxygen species and ferrous ion accumulation, and enhances glutathione peroxidase GPX4 activity, consequently inhibiting macrophage phagocytosis of oxidized low-density lipoprotein and foam cell development. -
Ferroptosis Inducer
Ferroptosis inducer-2 is a potent inducer of heme oxygenase-1 (HO-1) that facilitates the process of ferroptosis. It demonstrates significant anticancer activity against triple-negative breast cancer (TNBC) cells by promoting iron-dependent cell death. This compound is valuable for research focused on exploring the mechanisms of ferroptosis and developing novel therapeutic strategies for cancer treatment. -
Ferroptosis Inducer
Ferroptosis inducer-1 (BX-3a) is a potent inducer of ferroptosis, a form of regulated cell death characterized by iron-dependent lipid peroxidation. This compound exhibits antitumor activity and serves as a valuable tool for investigating ferroptosis pathways in cancer research. Ferroptosis inducer-1 features an alkyne group, enabling it to participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) with azide-containing molecules, facilitating advanced chemical biology applications. -
Ferroptosis/NETosis Inhibitor
IM-93 is a potent inhibitor of ferroptosis and NETosis, with an IC50 of 0.45 µM for the inhibition of cell death. This compound serves as a valuable tool for researchers investigating the mechanisms of ferroptosis and NETosis in various biological contexts. Its ability to modulate these cell death pathways can aid in the exploration of therapeutic strategies for diseases associated with oxidative stress and inflammation. -
Ferroptosis Inhibitor
Ferroptosis-IN-19 is a potent ferroptosis inhibitor exhibiting an IC50 value of 0.097 μM. This compound demonstrates high metabolic stability and favorable predictions for blood-brain barrier permeation. Ferroptosis-IN-19 has been shown to provide neuroprotective effects in vivo against ischemic brain injury in murine models, making it a valuable tool for exploring ferroptosis in neurological research. -
Ferroptosis Inhibitor
Ferroptosis-IN-8 is a potent ferroptosis inhibitor with an EC50 of 40.49 nM. This compound effectively lowers lipid reactive oxygen species (ROS) levels in cellular systems. By acting as an antioxidant that captures lipid radicals, Ferroptosis-IN-8 mitigates the accumulation of detrimental lipid peroxides, thereby inhibiting the ferroptotic process. This reagent is valuable for research in cell death mechanisms and oxidative stress. -
Ferroptosis Inhibitor
Ferroptosis-IN-21 is a selective ferroptosis inhibitor that mitigates renal ischemia/reperfusion (I/R) injury by suppressing ferroptosis and effectively scavenging peroxyl radicals. Demonstrating nanomolar potency, it exhibits significant anti-ferroptotic activity in renal tubular epithelial cells, leading to a marked reduction in lipid reactive oxygen species (ROS) and lipid peroxidation biomarkers such as 4-hydroxynonenal. In preclinical studies, Ferroptosis-IN-21 has shown to alleviate histological damage and functional impairment in mice models of renal I/R injury, making it a valuable reagent for research in ferroptosis-targeted therapeutic development. -
Ferroptosis Inhibitor
Ferroptosis-IN-22 is a selective ferroptosis inhibitor that targets and disrupts the interaction between NCOA4 and ferritin, demonstrating an EC50 of 520 nM and a Kd of 0.78 μM. This compound exhibits potent inhibitory activity against ferroptosis induced by agents such as RSL3, Erastin, ML210, and FIN56, while sparing necrosis and apoptosis pathways. Ferroptosis-IN-22 has shown efficacy in ameliorating acute liver injury induced by Concanavalin A, making it a valuable tool for research in ferroptosis-related diseases. -
Ferroptosis Inducer
BCP-T.A is a tunable heterocyclic electrophile that functions as a potent inducer of ferroptosis by targeting glutathione peroxidase 4 (GPX4). This compound possesses an alkyne group, enabling it to participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) reactions with azide-containing molecules. BCP-T.A is valuable for studies on ferroptosis mechanisms and the development of therapeutic strategies targeting this regulated form of cell death. -
Ferroptosis Inducer
FINO2 is a potent inducer of ferroptosis, primarily acting through the inhibition of GPX4 activity. This reagent is a stable oxidant that facilitates the oxidation of ferrous iron and is effective across a range of pH levels. Its mechanism drives extensive lipid peroxidation, making it a valuable tool for research into ferroptosis and related cellular death pathways. -
xc(-) Cystine/Glutamate Transporter System Inhibitor, ferroptosis inducer
Erastin2 is a selective inhibitor of the xc(-) cystine/glutamate transporter, functioning as a potent inducer of ferroptosis. This compound disrupts intracellular cystine availability, leading to increased oxidative stress and subsequent cell death. Erastin2 is valuable for research applications targeting ferroptosis in cancer biology and neurodegenerative diseases, providing insights into therapeutic strategies that exploit this regulated cell death pathway. -
Ferroptosis inhibitor
Trans-3-Indoleacrylic acid is a ferroptosis inhibitor that acts through modulation of the AHR-ALDH1A3-FSP1-CoQ10 axis. It has been shown to promote tumor development by inhibiting RSL3-induced ferroptosis, thereby contributing to the progression of colorectal carcinogenesis. This compound serves as a valuable tool for research into ferroptosis mechanisms and cancer biology. -
Ferroptosis Inducer
N6F11 is a selective ferroptosis inducer that targets TRIM25 to promote the degradation of GPX4 in cancer cells while preserving immune cell functionality. This compound triggers HMGB1-dependent antitumor immunity, activating CD8+ T cells and enhancing the immune response against tumors. N6F11 is suitable for research applications focused on cancer therapy and the mechanisms underlying ferroptosis. -
Ferroptosis Inhibitor
84-B10 is a potent ferroptosis inhibitor derived from 3-phenylglutaric acid. It effectively inhibits cisplatin-induced tubular ferroptosis, thereby mitigating mitochondrial damage and oxidative stress associated with cisplatin treatment. Consequently, 84-B10 demonstrates protective effects against cisplatin-induced acute kidney injury (AKI), making it a valuable reagent for research on drug-induced nephrotoxicity and ferroptosis-related mechanisms. -
ZIKV And EBOV Inhibitor, Histone H3 Acetylation Inductor, Ferroptosis Inductor
Cephaeline is a phenolic alkaloid derived from the roots of Cephaelis ipecacuanha, functioning as a potent inhibitor of Zika virus (ZIKV) and Ebola virus (EBOV) infections. It induces histone H3 acetylation, playing a role in epigenetic regulation, and has been shown to induce ferroptosis in mucoepidermoid carcinoma cancer stem cells by inhibiting NRF2. This makes Cephaeline a valuable reagent for researchers studying antiviral mechanisms and ferroptosis in cancer therapy. -
Ferroptosis Inhibitor
Liproxstatin-1 hydrochloride is a potent inhibitor of ferroptosis, a regulated form of cell death characterized by lipid peroxidation. It effectively prevents ferroptotic cell death with an IC50 value of 22 nM. This compound is valuable for research applications focused on oxidative stress, neurodegenerative diseases, and cancer, where modulating ferroptosis may provide therapeutic insights. -
Ferroptosis Inhibitor
YL-939 is a potent inhibitor of ferroptosis, a regulated form of cell death characterized by the accumulation of lipid peroxides. It acts by targeting the PHB2/ferritin/iron axis, effectively modulating iron metabolism and oxidative stress. This compound is valuable for research applications focused on neurodegeneration, cancer, and other diseases where ferroptosis plays a critical role. -
Ferroptosis Inhibitor
CuATSM is a copper complex that serves as a potent inhibitor of ferroptosis through the scavenging of free radicals and inhibition of lipid peroxidation. This compound demonstrates significant antioxidant and anti-inflammatory properties, making it valuable for addressing neuroprotection in various research contexts. CuATSM is suitable for studies exploring cellular stress responses and neurodegenerative disorders. -
Ferroptosis Inducer
Piperazine Erastin is a ferroptosis inducer that triggers an iron-dependent form of non-apoptotic cell death. This compound is instrumental in cancer research, providing valuable insights into the mechanisms of ferroptosis and potential therapeutic applications in oncology. Its unique action offers a powerful tool for studying cellular metabolism and death pathways in various cancer models. -
Ferroptosis Inducer
Angelic acid is a ferroptosis inducer that targets NRF2 degradation. By binding to the NRF2 protein, it facilitates its ubiquitination and subsequent proteasomal degradation, thereby mitigating the protective effects of NRF2 against oxidative stress and promoting lipid peroxidation. This process leads to the induction of ferroptosis in tumor cells, evidenced by increased intracellular reactive oxygen species (ROS) and upregulation of ferroptosis-related markers such as CHAC1 and PTGS2. Additionally, Angelic acid exhibits the ability to scavenge UVA-induced ROS, inhibiting skin fibroblast senescence and extracellular matrix degradation, and promotes wound healing through its sedative properties. -
Ferroptosis/ATF3 Inhibitor
ATF3-IN-1 is a potent inhibitor of ATF3, targeting the ATF3/SLC7A11/GPX4 pathway to mitigate ferroptosis and oxidative stress. This compound demonstrates significant neuroprotective effects, particularly in conditions of ischemia/reperfusion (I/R) injury, promoting neuronal survival in ischemic stroke models. ATF3-IN-1 is valuable for research into therapeutic strategies for neuroprotection and the underlying mechanisms of ischemic stroke. -
Ferroptosis Inhibitor
Moracin N is a potent ferroptosis inhibitor derived from mulberry leaves. It demonstrates neuroprotective activity by mitigating oxidative stress, providing valuable insights into the mechanisms of cell survival under stress conditions. This compound is applicable in research exploring neurodegenerative diseases and ferroptosis-related pathways. -
Apoptotis/Ferroptosis Activator
Ardisiacrispin B is an apoptosis and ferroptosis activator. It exhibits cytotoxic effects in cancer cells that are resistant to multiple treatments, promoting cell death through the induction of ferroptosis and apoptosis pathways. This compound is valuable for research applications focused on understanding resistance mechanisms in cancer and exploring therapeutic strategies that leverage ferroptotic cell death. -
Ferroptosis Inhibitor
SRS16-86 is a potent ferroptosis inhibitor that provides enhanced stability in vivo compared to other inhibitors. This compound is effective in research applications involving renal ischemia-reperfusion injury and spinal cord injury, making it a valuable tool for investigating ferroptosis-related pathways and therapeutic interventions. SRS16-86 allows researchers to explore the mechanisms of ferroptosis and its implications in various diseases. -
15-LO inhibitor
PD146176 (NSC168807) is a 15-Lipoxygenase (15-LO) inhibitor, which inhibits rabbit reticulocyte 15-LO with a Ki of 197 nM. PD146176 (NSC168807) has a dramatic effect in reducing atherogenesis. - Butylated hydroxytoluene is di-tert-butyl PHENOL with antioxidant properties.
-
non-essential amino acid
DL-Glutamine (Glutamin, 2-amino-4-carbamoylbutanoic acid) is a non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes. -
chelating agent
Ethylenediaminetetraacetic acid trisodium salt (EDTA trisodium salt) is used to bind metal ions in the practice of chelation therapy, for treating mercury and lead poisoning, used in a similar manner to remove excess iron from the body, for treating the complication of repeated blood transfusions, as would be applied to treat thalassaemia. -
thromboxane A2 (TXA2) receptor (TP receptor) antagonist
Seratrodast is a thromboxane A2 (TXA2) receptor (TP receptor) antagonist used primarily in the treatment of asthma. -
Bcl-2 Family activator
(E)-Ferulic acid is a isomer of Ferulic acid which is an aromatic compound, abundant in plant cell walls. (E)-Ferulic acid shows a potent ability to remove reactive oxygen species (ROS) and inhibits lipid peroxidation. (E)-Ferulic acid exerts both anti-proliferation and anti-migration effects in the human lung cancer cell line H1299. -
iron-chelating drug
Deferiprone is the only orally active iron-chelating drug to be used therapeutically in conditions of transfusional iron overload. -
excitatory transmitter/agonist
L-Glutamic acid monosodium salt acts as an excitatory transmitter and an agonist at all subtypes of glutamate receptors (metabotropic, kainate, NMDA, and AMPA). (S)-Glutamic acid shows a direct activating effect on the release of DA from dopaminergic terminals. -
ferroptosis inhibitor
Liproxstatin-1 is a potent ferroptosis inhibitor and inhibits ferroptotic cell death (IC50=22 nM). -
Ferroptosis inhibitor
UAMC-3203 hydrochloride is a potent and selective Ferroptosis inhibitor with an IC50 of 12 nM. -
g-glutamylcysteine synthetase inhibitor
L-Buthionine-(S,R)-sulfoximine is a cell-permeable, potent, fast acting and irreversible inhibitor of g-glutamylcysteine synthetase and depletes cellular glutathione levels. - Artefenomel (OZ439) is a synthetic antimalarial agent with the artemisinin pharmacophore. Artefenomel (OZ439) is a long-acting artemisinin-related agent.
-
Ferroptosis Suppressor
Taurolithocholic acid is a bile acid recognized for its role as a ferroptosis suppressor. It activates the TGR5-PI3K/AKT-SREBP2 signaling pathway, leading to the upregulation of FADS2, which inhibits SFTSV-induced ferroptosis and viral replication, while also modulating pro-inflammatory cytokines such as IL-1β. In addition to its antiviral properties, taurolithocholic acid influences hepatocellular transport processes, promoting cholestatic effects. This compound serves as a valuable experimental model for studying hepatocellular cholestasis and provides insight into severe fever with thrombocytopenia syndrome without exhibiting cytotoxicity at concentrations ≤200 μM. -
Ferroptosis/DNA Damage Inducer
HJ03 is a potent inducer of ferroptosis that targets DNA damage pathways. It enhances intracellular reactive oxygen species (ROS) levels, facilitates Fe2+ accumulation, and promotes lipid peroxidation, ultimately leading to the induction of DNA adducts and interstrand crosslinks. By inhibiting DNA replication and transcription, HJ03 effectively arrests the cell cycle at the G2/M phase and triggers apoptosis. This reagent is valuable for investigating glioblastoma multiforme and colorectal cancer research.
